Skip to main content

Novavax says its vaccine protects against Omicron variant, according to early data

Novavax has been studying its vaccine’s effectiveness against the newly emerged Omicron variant of Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.